misonidazole has been researched along with 1-(4'-hydroxy-2'-butenoxy)methyl-2-nitroimidazole in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (44.44) | 18.7374 |
1990's | 10 (55.56) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Baba, N; Manabe, T; Sakaguchi, M; Sasai, K; Shibamoto, Y; Takahashi, M | 1 |
Hata, K; Mashiba, H; Matsunaga, K | 1 |
Abe, M; Kitakabu, Y; Sakaguchi, M; Sasai, K; Shibamoto, Y; Streffer, C; Tamulevicius, P | 1 |
Suda, H | 1 |
Mori, T; Murayama, C | 3 |
Mori, T | 1 |
Akaishi, S; Kobari, M; Kodera, T; Matsuno, S; Sakamoto, K | 1 |
Fukuda, H; Hori, H; Inayama, S; Nakajima, T; Onoyama, Y; Sugimoto, K; Tanaka, M | 1 |
Abe, M; Kagiya, T; Mi, FS; Nishimoto, S; Sasai, K; Shibamoto, Y; Takahashi, M | 1 |
Miyamoto, Y; Mori, T; Murayama, C; Sakaguchi, M; Tanaka, N | 1 |
Miyamato, Y | 1 |
Goto, S; Inoue, H; Kato, T; Kim, NS; Mikami, Y; Miyata, K; Okubo, M; Sagitani, H; Umejima, H | 2 |
Streffer, C; Tamulevicius, P | 1 |
Baba, H; Emi, Y; Kusumoto, T; Maehara, Y; Sakaguchi, M; Sakaguchi, Y; Sugimachi, K | 1 |
Ebe, K; Honma, Y; Kuramitsu, T; Matsunaga, N; Miyata, Y; Nakanishi, T; Sakaguchi, M; Suda, H | 1 |
2 review(s) available for misonidazole and 1-(4'-hydroxy-2'-butenoxy)methyl-2-nitroimidazole
Article | Year |
---|---|
[Radiosensitizer: hypoxic cell radiosensitizer].
Topics: Animals; DNA; Dogs; Etanidazole; Hydroxamic Acids; Hydroxylation; Intercalating Agents; Lethal Dose 50; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Thymine | 1989 |
[Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Topics: Animals; Hydroxamic Acids; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
1 trial(s) available for misonidazole and 1-(4'-hydroxy-2'-butenoxy)methyl-2-nitroimidazole
Article | Year |
---|---|
Pharmacokinetics of intratumoral RK-28, a new hypoxic radiosensitizer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Misonidazole; Pancreatic Neoplasms; Radiation-Sensitizing Agents | 1992 |
15 other study(ies) available for misonidazole and 1-(4'-hydroxy-2'-butenoxy)methyl-2-nitroimidazole
Article | Year |
---|---|
Enhancement of radiosensitizing effect of the nitroimidazole derivative RK28 on the proliferation of MethA tumor cells in combined use with diethyldithiocarbamate.
Topics: Animals; Cell Division; Cobalt Radioisotopes; Ditiocarb; Drug Synergism; Mice; Mice, Inbred BALB C; Misonidazole; Radiation-Sensitizing Agents; Superoxide Dismutase; Tumor Cells, Cultured | 1991 |
Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
Topics: Animals; Cell Hypoxia; Cell Survival; Dogs; Evaluation Studies as Topic; Female; In Vitro Techniques; Male; Mice; Misonidazole; Rabbits; Radiation-Sensitizing Agents; Tissue Distribution | 1991 |
[Intraarterial infusion of hypoxic radiosensitizer RK28 in rabbit VX2 tumor system].
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Infusions, Intra-Arterial; Male; Misonidazole; Neoplasms, Experimental; Rabbits; Radiation-Sensitizing Agents | 1991 |
[Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
Topics: Cell Hypoxia; Etanidazole; Humans; Misonidazole; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1990 |
[Development of new hypoxic cell radiosensitizer in Japan].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Etanidazole; Hydroxamic Acids; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1988 |
[Experimental study of the intra-operative radiation therapy in pancreatic cancer].
Topics: Adenocarcinoma; Animals; Cell Division; Combined Modality Therapy; Cricetinae; Intraoperative Care; Mesocricetus; Misonidazole; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1988 |
[Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Topics: Animals; Chemical Phenomena; Chemistry; Drug Evaluation; Lethal Dose 50; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Rabbits; Radiation-Sensitizing Agents | 1988 |
[Radiosensitizing effects of new 2-nitroimidazole nucleoside analogues (RK-28, RK-29)].
Topics: Animals; Cell Survival; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1988 |
In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Combined Modality Therapy; Cricetinae; Cricetulus; HeLa Cells; Hypoxia; Mice; Mice, Inbred ICR; Misonidazole; Radiation-Sensitizing Agents; Sarcoma 180 | 1987 |
[Radiosensitizing effect of new hypoxic cell radiosensitizer, RK-28 on experimental animal normal tissue and Ehrlich tumor].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Male; Mice; Misonidazole; Radiation-Sensitizing Agents | 1985 |
Preparation and evaluation of suppositories for RK-28 (a new radiosensitizer) using rabbits.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Injections, Intravenous; Male; Misonidazole; Rabbits; Radiation-Sensitizing Agents; Suppositories | 1994 |
Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers.
Topics: Adenosine Triphosphate; Animals; Brain; Etanidazole; Glucose; Male; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1994 |
Pharmacokinetics of RK-28 (a new radiosensitizer) and pharmaceutical design of a suppository form using rats.
Topics: Administration, Oral; Administration, Rectal; Animals; Biological Availability; Dosage Forms; Dose-Response Relationship, Drug; Drug Design; Drug Stability; Half-Life; Injections, Intravenous; Male; Misonidazole; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Suppositories | 1994 |
Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
Topics: Animals; Cell Hypoxia; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice; Misonidazole; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured | 1993 |
Evaluation of the radiosensitizing effects of RK28 intravenous, intraarterial, and intratumoral injections on the rabbit VX2 tumor system.
Topics: Animals; Carcinoma, Squamous Cell; Injections, Intra-Arterial; Injections, Intravenous; Male; Misonidazole; Neoplasms, Experimental; Rabbits; Radiation-Sensitizing Agents | 1996 |